Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.American Pharmaceutical to merge with parent company
The new company will market and develop Abraxane, which is approved in the US for metastatic breast cancer and is being developed for adjuvant breast, lung, ovarian, prostate,
The new company will market and develop Abraxane, which is approved in the US for metastatic breast cancer and is being developed for adjuvant breast, lung, ovarian, prostate,
The results are a disappointment to the Swiss company as it seeks to expand the indication and market for its lead product. In the idiopathic pulmonary fibrosis (IPF)
“Understanding how personality is based in the brain is important both for insights into personality disorders and for conditions in which personality may confer vulnerability, such as anxiety
According to the study data, some traditional non-steroidal anti-inflammatory drugs (NSAIDs) can slightly increase the risk of non-fatal heart attack when taken regularly for more than one year.
The protein is the first clear target for modulating where viruses insert into the human genome, which has implications for better design of gene-therapy delivery. Retroviral vectors are
Previously, it was not known if zinc would speed up HIV disease progression in children by increasing their viral load. Zinc supplementation is known to decrease the frequency
The vaccine platform developed by Children’s Hospital of Pittsburgh researchers, working in collaboration with researchers from the University of Pittsburgh and Louisiana State University, suggests that the immune
The Commission concluded that the transaction would not significantly impede effective competition in the European economic area or any substantial part of it. Ivax is a US-based pharmaceutical
The most severe form of malaria, a disease that affects over 300 million people annually, is caused by the single-celled parasite plasmodium falciparum, which was the focus of
In a statement, IDM said that the transaction enables the company to focus on its five clinical-stage cancer programs, reduce its cash burn and increase its cash position.